Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Algerian laboratory Biopharm will enter a partnership worth $60m with the British lab, Astra Zeneca, to produce anticancer drugs.
Subscribe to our email newsletter
As per the deal, Astra Zeneca lab will choose between 250 anticancer drugs that will be produced in Algeria, bernama.com.my reported.
The agreement will be signed by end November
Algeria Minister of Health, Population and Hospital Reform Djamel Ould Abbes said Biopharm will contribute to achieving the objectives set by the State to cover 70% of national needs in the future.